A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: cediranib maleate|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)